Tag: pharmacokinetic
Orexo’s AmorphOX tech may pave way for intranasal GLP-1 medication
Orexo AB has announced positive pharmacokinetic in-vivo data for a powder-based intranasal semaglutide formulation developed with the AmorphOX technology.
In the in-vivo study, three different...
CuraTeQ Biologics’ successful phase 1 trial of BP11
CuraTeQ Biologics, a subsidiary of Aurobindo Pharma, announced that their Omalizumab biosimilar candidate BP11 has met the Phase 1 trial endpoints vis-à-vis the EU...